Morris T C, Vincent P C, Young G A, Sutherland R, Forrest P R, Irvine A E, Isbister J P
Haematology Department, Belfast City Hospital, Northern Ireland.
Clin Lab Haematol. 1989;11(1):31-45. doi: 10.1111/j.1365-2257.1989.tb00172.x.
Peripheral blood lymphocytes from 20 patients with neutropenia not consistent with aplastic anaemia were tested for their ability to inhibit the proliferation of normal granulopoietic precursor cells (CFU-GM) in agar culture. Two patients, both with features of an autoimmune disorder, had lymphocytes which were more inhibitory than normal lymphocytes to both normal and their own CFU-GM. Two other patients had lymphocytes which were more inhibitory than normal lymphocytes to either their own CFU-GM or normal CFU-GM but not both. Eight patients had lymphocytes which were significantly less inhibitory than normal lymphocytes to either normal or their own CFU-GM, but only one showed this feature against both normal and their own CFU-GM. One patient had a highly potent plasma inhibitor of CFU-GM--this patient had received multiple transfusions and had a leucocyte antibody of a broad specificity. No clinical or haematological features were common to any of these groups of patients which reflects the heterogeneity of patients studied and stresses the importance of controls.
对20例不符合再生障碍性贫血的中性粒细胞减少症患者的外周血淋巴细胞进行检测,以评估其在琼脂培养中抑制正常粒细胞前体细胞(CFU-GM)增殖的能力。两名患有自身免疫性疾病特征的患者,其淋巴细胞对正常和自身的CFU-GM的抑制作用均强于正常淋巴细胞。另外两名患者的淋巴细胞对自身CFU-GM或正常CFU-GM的抑制作用强于正常淋巴细胞,但并非对两者均有此作用。八名患者的淋巴细胞对正常或自身CFU-GM的抑制作用明显弱于正常淋巴细胞,但只有一名患者对正常和自身CFU-GM均表现出这一特征。一名患者有一种对CFU-GM具有高效力的血浆抑制剂——该患者接受过多次输血,且具有广泛特异性的白细胞抗体。这些患者组中没有共同的临床或血液学特征,这反映了所研究患者的异质性,并强调了对照的重要性。